Gd Searle Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GD SEARLE, and what generic and branded alternatives to GD SEARLE drugs are available?
GD SEARLE has twenty-eight approved drugs.
Drugs and US Patents for Gd Searle
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gd Searle Llc | PROCAINE HYDROCHLORIDE | procaine hydrochloride | INJECTABLE;INJECTION | 086202-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Gd Searle Llc | POTASSIUM CHLORIDE | potassium chloride | INJECTABLE;INJECTION | 086220-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Gd Searle Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 086418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Gd Searle Llc | ENOVID-E 21 | mestranol; norethynodrel | TABLET;ORAL-21 | 010976-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Gd Searle Llc | CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | CAPSULE;ORAL | 071729-001 | Dec 18, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Gd Searle Llc | ENOVID | mestranol; norethynodrel | TABLET;ORAL | 010976-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Gd Searle
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Gd Searle Llc | CU-7 | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 017408-001 | Approved Prior to Jan 1, 1982 | RE28399 | ⤷ Try a Trial |
Gd Searle Llc | CU-7 | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 017408-001 | Approved Prior to Jan 1, 1982 | 3,803,308 | ⤷ Try a Trial |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-003 | Nov 16, 2001 | 5,633,272 | ⤷ Try a Trial |
Gd Searle Llc | DEMULEN 1/35-28 | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-28 | 018160-001 | Approved Prior to Jan 1, 1982 | 3,483,221 | ⤷ Try a Trial |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-003 | Nov 16, 2001 | 7,135,489 | ⤷ Try a Trial |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-002 | Nov 16, 2001 | 5,633,272 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.